"Hope is not a good strategy, in life or in disease research. So the setting of goals, and the drive to reach them, is to be commended, and cancer is no exception. But a 2020 deadline for ‘ending’ breast cancer that former US President Bill Clinton endorsed earlier this month is misguided. Like other ‘beat cancer’ deadlines that are regularly floated, it is potentially harmful to the public trust that underpins the whole research enterprise, not to mention to the patients who understandably cling to hope, whatever its validity.
Clinton, who lost his mother to breast cancer, has become honorary chairman of a two-year-old campaign by the National Breast Cancer Coalition, which declares on its website that it has “One Mission: To End Breast Cancer by January 1, 2020”. The advocacy and research-funding organization, based in Washington DC, adds that it has a “strategic plan” to achieve that mission, by focusing on prevention and on eliminating the metastatic form of the disease, which is what kills.
The coalition provides a 4.5-page “blueprint”[PDF] that is long on aspiration and short on scientific detail. For instance, it declares that by 2020 “we must understand how to prevent people from getting breast cancer in the first place”. This goal leans heavily on the development of a preventive breast-cancer vaccine. A research plan for this is said to be “in place” and will serve as a model for other, “catalytic projects”. These could include exploiting the role of viruses and inflammation in breast cancer, and targeting the immune system to prevent metastasis"
Btw, for as long as I've known, since the late 80s at least, cancer research charities have raised enormous amounts on money and spent it on pure research that had nothing directly to do with cancer even. Things like protein folding, and even things like artificial intelligence and computer vision research that might indirectly help with work on protein folding and scanning cell images.I can't get over how incredibly wrong this is.
If your theory is "Give me a few billion, then go away and let me do whatever I want for a few decades", they already tried that.
Yes cancer is hard. But the approach to finding a cure has been nothing short of shameful in its disorganization and lack of focus and coordination. You have teams of scientists duplicating work, working at the margins of the issues, and corporations pouring most funds into trying to find a marketable product which frequently does little but extend life by a few weeks in terminal cases. What every woman is hoping for is not to get the disease in the first place, yet only about 5% of the research money goes to finding best prevention methodology. Not much is going to fundamental research to illuminate what causes cancer in the first place. Most goes to finding cures - preferably ones which can be sold by big pharma - once the disease has been established. It would be like focusing 95% of your money on finding a drug to cure lung cancer while ignoring smoking as a cause altogether.I find little to agree with here, either. Typically, duplicating work is a feature of science, not a bug. If this happens in a very promising avenue of research, it means that nothing is missed, and that the work is replicated in parallel rather than in serial.
« Older An eminent former editor of the Oxford English Dic... | According to multiple sources,... Newer »
This thread has been archived and is closed to new comments
posted by TwelveTwo at 8:47 AM on November 29, 2012